ADVENTRX: Company

MISSION & STRATEGY

STRATEGY

CLINICAL & REGULATORY STRATEGY

COMMERCIALIZATION

HISTORY

TEAM

TEAM

ADVENTRX Pharmaceuticals, Inc. is directed by a highly experienced biopharmaceutical management team. Disciplines include clinical medicine, product development, technology acquisition and development, venture capital financing, corporate licensing, and regulatory and legal affairs.

ADVENTRX Officers	ADVENTRX Board of Directors	ADVENTRX Scientific Advisory Board
Evan M. Levine Chief Executive Officer and President Mark N.K. Bagnall, C.P.A Chief Financial Officer & Executive Vice President Joan M. Robbins, Ph.D. Chief Scientific Officer, Senior Vice President Brian M. Culley, Masters, M.S., M.B.A. Chief Business Officer, Senior Vice President of Business Development Patrick Keran, J.D. General Counsel, Vice President Joachim P. H. Schupp, M.D. Vice President of Medical Affairs Mark Cantwell, Ph.D. Vice President of Research & Development Michele Yelmene Vice President of Regulatory Affairs Mark E. Erwin Vice President of Commercialization Jose R. Hechavarria Vice President of Manufacturing	Jack Lief Chairman Mark N. K. Bagnall, C.P.A. Chief Financial Officer & Executive Vice President Alexander J. Denner, Ph.D. Director Michael M. Goldberg M.D., M.B.A. Director Evan M. Levine Chief Executive Officer and President Mark Pykett, V.M.D., Ph.D., M.B.A. Director Eric K. Rowinsky, M.D. Director	Bengt G. Gustavsson, M.D., Ph.D. Department of Surgery, Sahlgrenska University Hospital, University of Göteborg Edward Chu, M.D. Professor of Medicine and Pharmacology, Yale University School of Medicine Richard J. Gralla, M.D. President, New York Cancer Alliance, Columbia University Daniel D. Von Hoff, M.D. Prof of Medicine, Pathology, Molecular & Cellular Biology, Director Arizona Health Sciences Cancer Center US Oncology, Chief Scientific Officer

[ back to top ]